Has Paul Alphonse, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,668 in general payments to Paul Alphonse, MD across 177 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Alphonse, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Alphonse, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Alphonse, MD

Urology · Roswell, GANPI 1720085624

Payments from drug & device makers

$5,668in general payments, 2019–2025

Across 177 payments — averaging $32.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Coloplast$1K
Teleflex LLC$795
Boston Scientific$740
Blue Earth Diagnostics$337
Astellas Pharma US Inc$319
Endo Pharmaceuticals Inc.$226
plus $2K from 37 others

What the payments were for

Travel & lodging$2284%
Food & beverage$5,34894%
Education$912%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Coloplast	30	$1,016
Teleflex LLC	5	$795
Boston Scientific	15	$740
Blue Earth Diagnostics	13	$337
Astellas Pharma US Inc	14	$319
Endo Pharmaceuticals Inc.	13	$226
Accord Healthcare, Inc.	2	$180
Pfizer	12	$168
Ambu Inc.	5	$134
Sumitomo Pharma America, Inc.	5	$129
Myovant Sciences Inc.	5	$114
Neotract Inc.	5	$112
Procept Biorobotics Corporation	5	$111
Boehringer Ingelheim	1	$109
Tolmar, Inc.	4	$103
KARL Storz Endoscopy-america	1	$100
AbbVie	4	$90
Dendreon Pharmaceuticals LLC	3	$88
ABC Home Medical Supply, Inc.	3	$73
180 Medical, Inc.	3	$71
Hologic Sales And Service, LLC	1	$70
Innovation Technologies Inc	2	$46
Bayer	2	$40
Olympus America Inc.	2	$39
Angiodynamics, Inc.	1	$38
C. R. Bard, Inc. & Subsidiaries	1	$37
Cumberland Pharmaceuticals, Inc.	1	$34
Medtronic(2 entities)	2	$33
Laborie Medical Technologies Corp.	2	$30
Kowa Pharmaceuticals America, Inc.	2	$30
Merck	1	$30
Johnson & Johnson	1	$23
Novartis	1	$23
Photocure Inc	1	$21
Dentsply IH AB	1	$20
Immunitybio, Inc.	1	$20
Telix Pharmaceuticals	1	$20
Tolmar Pharmaceuticals, Inc.	1	$19
BD	1	$18
Amgen	1	$17
Antares Pharma, Inc.	1	$16
Mallinckrodt Enterprises LLC	1	$15
Ferring Pharmaceuticals Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,668 in reported general payments places this provider in the 55th percentile of 369 urology providers in Georgia.

See all urology providers in Georgia →

Medicare billing

Part B allowed, 2024

$78,954

Medicare patients

230

Services billed

740

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	233	$4,127
Bethanechol Chloride	25	$1,233
Estradiol	19	$871
Alfuzosin Hcl ErAlfuzosin Hcl	45	$691
Finasteride	52	$568
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	37	$288
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	54	$191
Oxybutynin Chloride	33	$105
Cephalexin	20	$84
Levofloxacin	13	$52

Paid to pharmacies, not to this prescriber.

Other urology in Roswell

Vahan KassabianRoswell$3M
Lewis KritemanRoswell$864K
Scott MillerRoswell$85K
Akash KapadiaRoswell$79K
Herman BaggaRoswell$67K
Sophia GoodridgeRoswell$18K
Daniel BelewRoswell$16K
Viraj MasterAtlanta$2M
Vikram NarayanAtlanta$1.1M
Daniel CanterDecatur$611K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →